In this week’s View, Dr. Eagle explores a JACC State-of-the-Art Review of consumer wearable health and fitness technology and its role in cardiovascular medicine. He then discusses the 2023 update of the European Atherosclerosis Society’s consensus statement on homozygous familial hypercholesterolemia that offers new treatments and clinical guidance. Finally, Dr. Eagle looks at a recent post-hoc analysis of the SPRINT Trial on the effect of frailty on the efficacy and safety of intensive blood pressure control. 

Subscribe to Eagle’s Eye View